Össur hf. provided earnings guidance for the year 2022. For the period, the company's organic sales growth is expected to be in the range of 6% to 9%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29 DKK | -1.69% | -1.02% | +5.65% |
Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.65% | 1.79B | |
-1.49% | 17.77B | |
+7.25% | 13.85B | |
+8.24% | 10.07B | |
-8.16% | 2.3B | |
+33.51% | 1.64B | |
+20.00% | 625M | |
0.00% | 390M | |
+37.26% | 159M | |
+20.48% | 93.56M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur Hf. Provides Earnings Guidance for the Year 2022